ScholarIQanswers from OpenAlex
Bristol-Myers Squibb (Germany)
InstitutionResearch output, impact & collaborations
Bristol-Myers Squibb (Germany) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Bristol-Myers Squibb (Germany)?
ScholarIQrecord summary
Bristol-Myers Squibb (Germany) is a research organisation in Munich, DE. OpenAlex records 8,982 works and 1,524,913 citations for it. 3,239 researchers list it as their most recent affiliation.
How many works does Bristol-Myers Squibb (Germany) have?
ScholarIQindexed works
Bristol-Myers Squibb (Germany) has 8,982 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bristol-Myers Squibb (Germany) have?
ScholarIQcitation count
Bristol-Myers Squibb (Germany) has 1,524,913 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Bristol-Myers Squibb (Germany)?
ScholarIQresearcher count
Bristol-Myers Squibb (Germany) has 3,239 researchers in the ScholarIQ index.
What is the average h-index at Bristol-Myers Squibb (Germany)?
ScholarIQavg h-index
Bristol-Myers Squibb (Germany) has an average h-index of 51 in OpenAlex.
What is the ROR of Bristol-Myers Squibb (Germany)?
ScholarIQror
The ROR for Bristol-Myers Squibb (Germany) is on the source record.
What is the OpenAlex record for Bristol-Myers Squibb (Germany)?
ScholarIQopenalex
The OpenAlex for Bristol-Myers Squibb (Germany) is on the source record.
What is the Wikidata of Bristol-Myers Squibb (Germany)?
ScholarIQwikidata
The Wikidata for Bristol-Myers Squibb (Germany) is on the source record.
Who are the most-cited researchers behind Bristol-Myers Squibb (Germany)?
ScholarIQtop researchers by citations
What are the most-cited papers on Bristol-Myers Squibb (Germany)?
ScholarIQmost cited works
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott Gettinger, David C. Smith, David F. McDermott, John D. Powderly, Richard D. Carvajal, Jeffrey A. Sosman, Michael B. Atkins, Philip D. Leming, David R. Spigel, Scott Antonia, Leora Horn, Charles G. Drake, Drew M. Pardoll, Lieping Chen, William H. Sharfman, Robert A. Anders, Janis M. Taube, Tracee L. McMiller, Haiying Xu, Alan J. Korman, Maria Jure–Kunkel, Shruti Agrawal, D. G. McDonald, Georgia Kollia, Ashok Gupta, Jon M. Wigginton, Mario Sznol
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow, Wen-Jen Hwu, Suzanne L. Topalian, Patrick Hwu, Charles G. Drake, Luis H. Camacho, John Kauh, Kunle Odunsi, Henry C. Pitot, Omid Hamid, Shailender Bhatia, Renato Martins, Keith D. Eaton, Shuming Chen, Theresa M. Salay, Suresh Alaparthy, Joseph F. Grosso, Alan J. Korman, Susan Parker, Shruti Agrawal, S. Goldberg, Drew M. Pardoll, Ashok Gupta, Jon M. Wigginton
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer, Charles G. Drake, Ira Wollner, John D. Powderly, Joel Picus, William H. Sharfman, Elizabeth Stankevich, Alice Pons, Theresa M. Salay, Tracee L. McMiller, Marta M. Gilson, Changyu Wang, Mark Selby, Janis M. Taube, Robert A. Anders, Lieping Chen, Alan J. Korman, Drew M. Pardoll, Israel Lowy, Suzanne L. Topalian
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Yukinori Okada, Di Wu, Gosia Trynka, Towfique Raj, Chikashi Terao, Katsunori Ikari, Yuta Kochi, Koichiro Ohmura, Akari Suzuki, Shinji Yoshida, Robert Graham, Arun Manoharan, Ward Ortmann, Tushar Bhangale, Joshua C. Denny, Robert J. Carroll, Anne E. Eyler, Jeffrey D. Greenberg, Joel M. Kremer, Dimitrios A. Pappas, Lei Jiang, Jian Yin, Lingying Ye, Ding‐Feng Su, Jian Yang, Gang Xie, Ed Keystone, Harm-Jan Westra, Tõnu Esko, Andres Metspalu, Xuezhong Zhou, Namrata Gupta, Daniel B. Mirel, Eli A. Stahl, Dorothée Diogo, Jing Cui, Katherine P. Liao, Michael H. Guo, Keiko Myouzen, Takahisa Kawaguchi, Marieke J. H. Coenen, Piet L. C. M. van Riel, Mart A F J van de Laar, Henk‐Jan Guchelaar, T. Huizinga, Philippe Dieudé, Xavier Mariette, S. Louis Bridges, Alexandra Zhernakova, René E. M. Toes, Paul P. Tak, Corinne Miceli‐Richard, So‐Young Bang, Hye‐Soon Lee, Javier Martı́n, Miguel Á. González‐Gay, Luis Rodríguez‐Rodríguez, Solbritt Rantapää‐Dahlqvist, Lisbeth Ärlestig, Hyon K. Choi, Yoichiro Kamatani, Pilar Galán, Mark Lathrop, Steve Eyre, John Bowes, Anne Barton, Niek de Vries, Larry W. Moreland, Lindsey A. Criswell, Elizabeth W. Karlson, Atsuo Taniguchi, Ryo Yamada, Michiaki Kubo, Jun S. Liu, Sang‐Cheol Bae, Jane Worthington, Leonid Padyukov, Lars Klareskog, Peter K. Gregersen, Soumya Raychaudhuri, Barbara E. Stranger, Philip L. De Jager, Lude Franke, Peter M. Visscher, Matthew A. Brown, Hisashi Yamanaka, Tsuneyo Mimori, Atsushi Takahashi, Huji Xu, Timothy W. Behrens, Katherine Siminovitch, Shigeki Momohara, Fumihiko Matsuda, Kazuhiko Yamamoto, Robert M. Plenge
Genomic atlas of the human plasma proteome
Benjamin B. Sun, Joseph Maranville, James E. Peters, David Stacey, James R Staley, James Blackshaw, Stephen Burgess, Tao Jiang, Ellie Paige, Praveen Surendran, Clare Oliver‐Williams, Mihir Kamat, Bram P. Prins, Sheri K. Wilcox, Erik S. Zimmerman, An Chi, Narinder Bansal, Sarah L. Spain, Angela Wood, Nicholas W. Morrell, John R. Bradley, Nebojša Janjić, David J. Roberts, Willem H. Ouwehand, John A. Todd, Nicole Soranzo, Karsten Suhre, Dirk S. Paul, Caroline S. Fox, Robert M. Plenge, John Danesh, Heiko Runz, Adam S. Butterworth
Who collaborates most closely around Bristol-Myers Squibb (Germany)?
ScholarIQco-authorship network
United States
100%
MOST FREQUENT PARTNER INSTITUTIONS
How much of the research on Bristol-Myers Squibb (Germany) is open access?
ScholarIQopen access share
83%OPEN ACCESS